Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.830
0.00 (0.00%)
Jul 21, 2026, 9:34 AM EDT - Market open
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $399.79 million as of July 21, 2026. Its market cap has increased by 94.52% in one year.
Market Cap
399.79M
Enterprise Value
203.18M
1-Year Change
94.52%
Ranking
Category
Stock Price
$3.83
ChartMarket Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $399.79M, an increase of 252.60%. That is a compound annual growth rate of 22.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 399.79M | 22.60% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 422.47M |
| Evommune | 417.27M |
| Benitec Biopharma | 414.31M |
| vTv Therapeutics | 409.51M |
| Prelude Therapeutics | 402.66M |
| C4 Therapeutics | 395.83M |
| Century Therapeutics | 394.98M |
| Enanta Pharmaceuticals | 382.67M |